Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS

Completed · Phase 1

Conditions studied: Multiple Sclerosis

In brief

The purpose of this study is to learn about the pharmacokinetics and pharmacodynamics of RPC1063 in RMS.

Key facts

Study ID

NCT02797015

Run by

Celgene

People needed

22

Starts

2016-06-23

Expected to finish

2017-10-20

Last updated by the study team

2018-03-27

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Breastlink Medical Group, Inc. — Long Beach, California, United States
• Multiple Sclerosis Center at UCSF — San Francisco, California, United States
• Raleigh Neurology Associates PA — Raleigh, North Carolina, United States
• Neurology and Neuroscience Associates Inc. — Akron, Ohio, United States
• Hope Neurology MS Center — Knoxville, Tennessee, United States
• Central Texas Neurology Consultants PA — Round Rock, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.